تعديل

Affichage des articles dont le libellé est FDA to review Roche's bladder cancer drug on priority basis. Afficher tous les articles
Affichage des articles dont le libellé est FDA to review Roche's bladder cancer drug on priority basis. Afficher tous les articles

mardi 15 mars 2016

FDA to review Roche's bladder cancer drug on priority basis

ZURICH (Reuters) - The U.S. Food and Drug Administration has granted a priority review status to Roche's immunotherapy to treat advanced bladder cancer, the Swiss pharmaceutical maker said on Tuesday.











http://ift.tt/1S1cGRu

from Reuters: Health News
via animenewspro